Cholinergic receptors modulate immune complex-induced inflammation in vitro and in vivo

Journal of Immunology

Volumn 191, Issue 4, 2013, Pages 1800-1807

  Vukelic, Milena ^a   Qing, Xiaoping ^a   Redecha, Patricia ^a   Koo, Gloria ^a   Salmon, Jane E ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; BUNGAROTOXIN RECEPTOR; CHEMOKINE; CHOLINERGIC RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR; CXCL1 CHEMOKINE; CYTOKINE; FC RECEPTOR; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTHUS PHENOMENON; ARTICLE; CELL INFILTRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ADHERENCE; MONONUCLEAR PHAGOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ACETYLCHOLINE; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; ASCITIC FLUID; BENZYLIDENE COMPOUNDS; CELL ADHESION; CELLS, CULTURED; CHEMOKINE CXCL1; CHEMOTAXIS, LEUKOCYTE; COMPLEMENT C5A; CYTOKINES; FEMALE; HUMANS; I-KAPPA B KINASE; IMMUNE COMPLEX DISEASES; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; NICOTINE; NICOTINIC AGONISTS; PHAGOCYTES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PYRIDINES; REACTIVE OXYGEN SPECIES; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, IGG; RECOMBINANT PROTEINS; RESPIRATORY BURST; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 84881436474     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203467     Document Type: Article

References (54)

1. Tracey, K. J. 2009. Reflex control of immunity. Nat. Rev. Immunol. 9: 418-428.
2. Olofsson, P. S., M. Rosas-Ballina, Y. A. Levine, and K. J. Tracey. 2012. Rethinking inflammation: neural circuits in the regulation of immunity. Immunol. Rev. 248: 188-204.
3. Rosas-Ballina, M., P. S. Olofsson, M. Ochani, S. I. Valdés-Ferrer, Y. A. Levine, C. Reardon, M. W. Tusche, V. A. Pavlov, U. Andersson, S. Chavan, et al. 2011. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334: 98-101.
4. Andersson, U., and K. J. Tracey. 2012. Reflex principles of immunological homeostasis. Annu. Rev. Immunol. 30: 313-335.
5. von Känel, R., R. A. Nelesen, P. J. Mills, M. G. Ziegler, and J. E. Dimsdale. 2008. Relationship between heart rate variability, interleukin-6, and soluble tissue factor in healthy subjects. Brain Behav. Immun. 22: 461-468.
6. Sloan, R. P., H. McCreath, K. J. Tracey, S. Sidney, K. Liu, and T. Seeman. 2007. RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol. Med. 13: 178-184.
7. Haensel, A., P. J. Mills, R. A. Nelesen, M. G. Ziegler, and J. E. Dimsdale. 2008. The relationship between heart rate variability and inflammatory markers in cardiovascular diseases. Psychoneuroendocrinology 33: 1305-1312.
8. Marsland, A. L., R. Sathanoori, M. F. Muldoon, and S. B. Manuck. 2007. Stimulated production of interleukin-8 covaries with psychosocial risk factors for inflammatory disease among middle-aged community volunteers. Brain Behav. Immun. 21: 218-228.
9. Holguin, F., M. M. Téllez-Rojo, M. Lazo, D. Mannino, J. Schwartz, M. Hernández, and I. Romieu. 2005. Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest 127: 1102-1107.
10. Jae, S. Y., B. Fernhall, K. S. Heffernan, M. Jeong, E. M. Chun, J. Sung, S. H. Lee, Y. J. Lim, and W. H. Park. 2006. Effects of lifestyle modifications on C-reactive protein: contribution of weight loss and improved aerobic capacity. Metabolism 55: 825-831.
11. van Westerloo, D. J., I. A. Giebelen, S. Florquin, J. Daalhuisen, M. J. Bruno, A. F. de Vos, K. J. Tracey, and T. van der Poll. 2005. The cholinergic antiinflammatory pathway regulates the host response during septic peritonitis. J. Infect. Dis. 191: 2138-2148.
12. Borovikova, L. V., S. Ivanova, M. Zhang, H. Yang, G. I. Botchkina, L. R. Watkins, H. Wang, N. Abumrad, J.W. Eaton, and K. J. Tracey. 2000. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462.
13. Bernik, T. R., S.G. Friedman, M. Ochani, R. DiRaimo, L. Ulloa, H. Yang, S. Sudan, C. J. Czura, S. M. Ivanova, and K. J. Tracey. 2002. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J. Exp. Med. 195: 781-788.
14. Huston, J. M., M. Ochani, M. Rosas-Ballina, H. Liao, K. Ochani, V. A. Pavlov, M. Gallowitsch-Puerta, M. Ashok, C. J. Czura, B. Foxwell, et al. 2006. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J. Exp. Med. 203: 1623-1628.
15. Stojanovich, L., B. Milovanovich, S. R. de Luka, D. Popovich-Kuzmanovich, V. Bisenich, B. Djukanovich, T. Randjelovich, and M. Krotin. 2007. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjögren syndrome and other autoimmune diseases. Lupus 16: 181-185.
16. Aydemir, M., V. Yazisiz, I. Basarici, A. B. Avci, F. Erbasan, A. Belgi, and E. Terzioglu. 2010. Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus. Lupus 19: 255-261.
17. Laversuch, C. J., H. Seo, H. Modarres, D. A. Collins, W. McKenna, and B. E. Bourke. 1997. Reduction in heart rate variability in patients with systemic lupus erythematosus. J. Rheumatol. 24: 1540-1544.
18. Wang, Y., Q. Hu, J. A. Madri, S. A. Rollins, A. Chodera, and L. A. Matis. 1996. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc. Natl. Acad. Sci. USA 93: 8563-8568.
19. Atkinson, C., F. Qiao, H. Song, G. S. Gilkeson, and S. Tomlinson. 2008. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice. J. Immunol. 180: 1231-1238.
20. Nimmerjahn, F., and J. V. Ravetch. 2008. Fcγ receptors as regulators of immune responses. Nat. Rev. Immunol. 8: 34-47.
21. Bao, L., I. Osawe, T. Puri, J. D. Lambris, M. Haas, and R. J. Quigg. 2005. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur. J. Immunol. 35: 2496-2506.
22. Pricop, L., J. Gokhale, P. Redecha, S. C. Ng, and J. E. Salmon. 1999. Reactive oxygen intermediates enhance Fcγ receptor signaling and amplify phagocytic capacity. J. Immunol. 162: 7041-7048.
23. McPhail, L. C., and R. Snyderman. 1983. Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli: evidence that the same oxidase is activated by different transductional mechanisms. J. Clin. Invest. 72: 192-200.
24. Briggs, C. A., D. J. Anderson, J. D. Brioni, J. J. Buccafusco, M. J. Buckley, J. E. Campbell, M. W. Decker, D. Donnelly-Roberts, R. L. Elliott, M. Gopalakrishnan, et al. 1997. Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacol. Biochem. Behav. 57: 231-241.
25. Briggs, C. A., and D. G. McKenna. 1998. Activation and inhibition of the human α7 nicotinic acetylcholine receptor by agonists. Neuropharmacology 37: 1095-1102.
26. Meyer, E. M., E. T. Tay, R. L. Papke, C. Meyers, G. L. Huang, and C. M. de Fiebre. 1997. 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat α7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner. Brain Res. 768: 49-56.
27. Stevens, K. E., W. R. Kem, V. M. Mahnir, and R. Freedman. 1998. Selective α7- nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology 136: 320-327.
28. Kem, W. R. 2000. The brain α7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21). Behav. Brain Res. 113: 169-181.
29. Ward, J. M., V. B. Cockcroft, G. G. Lunt, F. S. Smillie, and S. Wonnacott. 1990. Methyllycaconitine: a selective probe for neuronal α-bungarotoxin binding sites. FEBS Lett. 270: 45-48.
30. 3H]methyllycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors. Neuropharmacology 38: 679-690.
31. Mogg, A. J., P. Whiteaker, J. M. McIntosh, M. Marks, A. C. Collins, and S. Wonnacott. 2002. Methyllycaconitine is a potent antagonist of α-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum. J. Pharmacol. Exp. Ther. 302: 197-204.
32. Escubedo, E., C. Chipana, M. Pérez-Sánchez, J. Camarasa, and D. Pubill. 2005. Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of α7 nicotinic receptors. J. Pharmacol. Exp. Ther. 315: 658-667.
33. Saeed, R. W., S. Varma, T. Peng-Nemeroff, B. Sherry, D. Balakhaneh, J. Huston, K. J. Tracey, Y. Al-Abed, and C. N. Metz. 2005. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J. Exp. Med. 201: 1113-1123.
34. Godau, J., T. Heller, H. Hawlisch, M. Trappe, E. Howells, J. Best, J. Zwirner, J. S. Verbeek, P. M. Hogarth, C. Gerard, et al. 2004. C5a initiates the inflammatory cascade in immune complex peritonitis. J. Immunol. 173: 3437-3445.
35. Shushakova, N., J. Skokowa, J. Schulman, U. Baumann, J. Zwirner, R. E. Schmidt, and J. E. Gessner. 2002. C5a anaphylatoxin is a major regulator of activating versus inhibitory FcγRs in immune complex-induced lung disease. J. Clin. Invest. 110: 1823-1830.
36. Huston, J. M., M. Rosas-Ballina, X. Xue, O. Dowling, K. Ochani, M. Ochani, M. M. Yeboah, P. K. Chatterjee, K. J. Tracey, and C. N. Metz. 2009. Cholinergic neural signals to the spleen down-regulate leukocyte trafficking via CD11b. J. Immunol. 183: 552-559.
37. Chatterjee, P. K., M. M. Yeboah, O. Dowling, X. Xue, S. R. Powell, Y. Al-Abed, and C. N. Metz. 2012. Nicotinic acetylcholine receptor agonists attenuate septic acute kidney injury in mice by suppressing inflammation and proteasome activity. PLoS One 7: e35361.
38. Andersson, U., and K. J. Tracey. 2012. Neural reflexes in inflammation and immunity. J. Exp. Med. 209: 1057-1068.
39. Rosas-Ballina, M., M. Ochani, W. R. Parrish, K. Ochani, Y. T. Harris, J. M. Huston, S. Chavan, and K. J. Tracey. 2008. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc. Natl. Acad. Sci. USA 105: 11008-11013.
40. Ghia, J. E., P. Blennerhassett, and S. M. Collins. 2008. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J. Clin. Invest. 118: 2209-2218.
41. Ghia, J. E., P. Blennerhassett, H. Kumar-Ondiveeran, E. F. Verdu, and S. M. Collins. 2006. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 131: 1122-1130.
42. van Westerloo, D. J., I. A. Giebelen, S. Florquin, M. J. Bruno, G. J. Larosa, L. Ulloa, K. J. Tracey, and T. van der Poll. 2006. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130: 1822-1830.
43. Guarini, S., D. Altavilla, M. M. Cainazzo, D. Giuliani, A. Bigiani, H. Marini, G. Squadrito, L. Minutoli, A. Bertolini, R. Marini, et al. 2003. Efferent vagal fibre stimulation blunts nuclear factor-κB activation and protects against hypovolemic hemorrhagic shock. Circulation 107: 1189-1194.
44. Neumann, S., M. Razen, P. Habermehl, C. U. Meyer, F. Zepp, C. J. Kirkpatrick, and I. Wessler. 2007. The non-neuronal cholinergic system in peripheral blood cells: effects of nicotinic and muscarinic receptor antagonists on phagocytosis, respiratory burst and migration. Life Sci. 80: 2361-2364.
45. Reardon, C., G. S. Duncan, A. Brüstle, D. Brenner, M. W. Tusche, P. S. Olofsson, M. Rosas-Ballina, K. J. Tracey, and T. W. Mak. 2013. Lymphocyte-derived ACh regulates local innate but not adaptive immunity. Proc. Natl. Acad. Sci. USA 110: 1410-1415.
46. Olofsson, P. S., D. A. Katz, M. Rosas-Ballina, Y. A. Levine, M. Ochani, S. I. Valdés-Ferrer, V. A. Pavlov, K. J. Tracey, and S. S. Chavan. 2012. α7 Nicotinic acetylcholine receptor (α7nAChR) expression in bone marrow-derived non-T cells is required for the inflammatory reflex. Mol. Med. 18: 539-543.
47. de Jonge, W. J., E. P. van der Zanden, F. O. The, M. F. Bijlsma, D. J. van Westerloo, R. J. Bennink, H. R. Berthoud, S. Uematsu, S. Akira, R. M. van den Wijngaard, and G. E. Boeckxstaens. 2005. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat. Immunol. 6: 844-851.
48. Wang, H., H. Liao, M. Ochani, M. Justiniani, X. Lin, L. Yang, Y. Al-Abed, H. Wang, C. Metz, E. J. Miller, et al. 2004. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10: 1216-1221.
49. van Maanen, M. A., M. C. Lebre, T. van der Poll, G. J. LaRosa, D. Elbaum, M. J. Vervoordeldonk, and P. P. Tak. 2009. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum. 60: 114-122.
50. van Maanen, M. A., S. P. Stoof, G. J. Larosa, M. J. Vervoordeldonk, and P. P. Tak. 2010. Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor α7 subunit gene knockout mice. Ann. Rheum. Dis. 69: 1717-1723.
51. Westman, M., S. Saha, M. Morshed, and J. Lampa. 2010. Lack of acetylcholine nicotine α7 receptor suppresses development of collagen-induced arthritis and adaptive immunity. Clin. Exp. Immunol. 162: 62-67.
52. van Maanen, M. A., S. P. Stoof, E. P. van der Zanden, W. J. de Jonge, R. A. Janssen, D. F. Fischer, N. Vandeghinste, R. Brys, M. J. Vervoordeldonk, and P. P. Tak. 2009. The α7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients: a possible role for a key neurotransmitter in synovial inflammation. Arthritis Rheum. 60: 1272-1281.
53. Pontet, J., P. Contreras, A. Curbelo, J. Medina, S. Noveri, S. Bentancourt, and E. R. Migliaro. 2003. Heart rate variability as early marker of multiple organ dysfunction syndrome in septic patients. J. Crit. Care 18: 156-163.
54. Louthrenoo, W., P. Ruttanaumpawan, A. Aramrattana, and W. Sukitawut. 1999. Cardiovascular autonomic nervous system dysfunction in patients with rheumatoid arthritis and systemic lupus erythematosus. QJM 92: 97-102.